Prostate cancer, version 1.2014.
Publication
, Journal Article
Mohler, JL; Kantoff, PW; Armstrong, AJ; Bahnson, RR; Cohen, M; D'Amico, AV; Eastham, JA; Enke, CA; Farrington, TA; Higano, CS; Horwitz, EM ...
Published in: J Natl Compr Canc Netw
December 1, 2013
The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer. This report highlights notable recent updates. Radium-223 dichloride is a first-in-class radiopharmaceutical that recently received approval for the treatment of patients with symptomatic bone metastases and no known visceral disease. It received a category 1 recommendation as both a first-line and second-line option. The NCCN Prostate Cancer Panel also revised recommendations on the choice of intermittent or continuous androgen deprivation therapy based on recent phase III clinical data comparing the 2 strategies in the nonmetastatic and metastatic settings.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 1, 2013
Volume
11
Issue
12
Start / End Page
1471 / 1479
Location
United States
Related Subject Headings
- Recurrence
- Radium
- Radioisotopes
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Staging
- Male
- Humans
- Bone Neoplasms
- 4203 Health services and systems
Citation
APA
Chicago
ICMJE
MLA
NLM
Mohler, J. L., Kantoff, P. W., Armstrong, A. J., Bahnson, R. R., Cohen, M., D’Amico, A. V., … National comprehensive cancer network, . (2013). Prostate cancer, version 1.2014. J Natl Compr Canc Netw, 11(12), 1471–1479. https://doi.org/10.6004/jnccn.2013.0174
Mohler, James L., Philip W. Kantoff, Andrew J. Armstrong, Robert R. Bahnson, Michael Cohen, Anthony Victor D’Amico, James A. Eastham, et al. “Prostate cancer, version 1.2014.” J Natl Compr Canc Netw 11, no. 12 (December 1, 2013): 1471–79. https://doi.org/10.6004/jnccn.2013.0174.
Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, et al. Prostate cancer, version 1.2014. J Natl Compr Canc Netw. 2013 Dec 1;11(12):1471–9.
Mohler, James L., et al. “Prostate cancer, version 1.2014.” J Natl Compr Canc Netw, vol. 11, no. 12, Dec. 2013, pp. 1471–79. Pubmed, doi:10.6004/jnccn.2013.0174.
Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kawachi MH, Kuettel M, Lee RJ, Macvicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Richey S, Roach M, Rohren E, Rosenfeld S, Small EJ, Srinivas S, Stein C, Strope SA, Tward J, Walsh PC, Shead DA, Ho M, National comprehensive cancer network. Prostate cancer, version 1.2014. J Natl Compr Canc Netw. 2013 Dec 1;11(12):1471–1479.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 1, 2013
Volume
11
Issue
12
Start / End Page
1471 / 1479
Location
United States
Related Subject Headings
- Recurrence
- Radium
- Radioisotopes
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Staging
- Male
- Humans
- Bone Neoplasms
- 4203 Health services and systems